AquaBounty Technologies, Inc. (LON:ABTU) Files An 8-K Other EventsItem 8.01Other Events.
On April26, 2018, the U.S. Food and Drug Administration (FDA) announced that it approved a supplemental New Animal Drug Application submitted by AquaBounty Technologies, Inc. (the “Supplemental NADA”). The Supplemental NADA requested FDA approval to raise AquAdvantage Salmon®, a product under an application previously approved in 2015, at a
land-based contained facility near Albany, Indiana. While the Indiana facility is approved for production, the company is prohibited from importing the eggs necessary for producing genetically engineered salmon at the facility because of a requirement in FDA’s current appropriations law.
On April27, 2018, AquaBounty Technologies, Inc. (the “Company”) issued a press release regarding approval of the Supplemental NADA. A copy of the press release is furnished herewith as Exhibit99.1 and is incorporated herein by reference.
Item 8.01Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
Description |
|
99.1 |
Press release issued by AquaBounty Technologies, Inc. on April 27, 2018, furnished herewith. |
AquaBounty Technologies, Inc. ExhibitEX-99.1 2 exhibit991-20180427.htm EXHIBIT 99.1 Exhibit AquaBounty Technologies,…To view the full exhibit click here
About AquaBounty Technologies, Inc. (LON:ABTU)
AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained, land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company’s subsidiaries include AquaBounty Canada, Inc., which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company’s technologies; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc., and AquaBounty Brasil Participacoes Ltda., which conducts commercial trials of the Company’s AquAdvantage Salmon.
